share_log
Moomoo 24/7 ·  Apr 11 08:30
Leap Therapeutics : Net Proceeds, Along With Existing Cash, Cash Equivalents, & Marketable Securities Are Expected to Extend Cash Runway Into Q2 2026
Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more
    Write a comment